Selected research
Industry Research
Glycan Analysis and Glycopeptide Analysis Industry Research Report 2026
Market perspective
The global Glycan Analysis and Glycopeptide Analysis market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Glycan Analysis and Glycopeptide Analysis market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Glycan Analysis and Glycopeptide Analysis market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Glycan Analysis and Glycopeptide Analysis market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Glycan Analysis and Glycopeptide Analysis include Thermo Fisher, Creative Proteomics, Bioinformatics Solutions Inc., Bruker, NIBSC, Waters, Ludger, Rapid Novor and FyonBio, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Glycan Analysis and Glycopeptide Analysis market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Glycan Analysis and Glycopeptide Analysis.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Glycan Analysis and Glycopeptide Analysis Market by Company
Thermo Fisher
Creative Proteomics
Bioinformatics Solutions Inc.
Bruker
NIBSC
Waters
Ludger
Rapid Novor
FyonBio
Prolytix
Agilent
Asparia Glycomics
Glycan Analysis and Glycopeptide Analysis Segment by Type
Glycan Analysis
Glycopeptide Analysis
Glycan Analysis and Glycopeptide Analysis Segment by Application
Scientific Research
Medical Diagnosis
Drug Development
Other
Glycan Analysis and Glycopeptide Analysis Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Glycan Analysis and Glycopeptide Analysis market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Glycan Analysis and Glycopeptide Analysis and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Glycan Analysis and Glycopeptide Analysis.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Glycan Analysis and Glycopeptide Analysis companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Glycan Analysis
- Glycopeptide Analysis
Applications
- Scientific Research
- Medical Diagnosis
- Drug Development
- Other
Companies covered
- Thermo Fisher
- Creative Proteomics
- Bioinformatics Solutions Inc.
- Bruker
- NIBSC
- Waters
- Ludger
- Rapid Novor
- FyonBio
- Prolytix
- Agilent
- Asparia Glycomics
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Glycan Analysis and Glycopeptide Analysis by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Glycan Analysis
- 2.2.3 Glycopeptide Analysis
- 2.3 Glycan Analysis and Glycopeptide Analysis by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Scientific Research
- 2.3.3 Medical Diagnosis
- 2.3.4 Drug Development
- 2.3.5 Other
- 2.4 Assumptions and Limitations
3 Glycan Analysis and Glycopeptide Analysis Breakdown Data by Type
- 3.1 Global Glycan Analysis and Glycopeptide Analysis Historic Market Size by Type (2021-2026)
- 3.2 Global Glycan Analysis and Glycopeptide Analysis Forecasted Market Size by Type (2027-2032)
4 Glycan Analysis and Glycopeptide Analysis Breakdown Data by Application
- 4.1 Global Glycan Analysis and Glycopeptide Analysis Historic Market Size by Application (2021-2026)
- 4.2 Global Glycan Analysis and Glycopeptide Analysis Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Glycan Analysis and Glycopeptide Analysis Market Perspective (2021-2032)
- 5.2 Global Glycan Analysis and Glycopeptide Analysis Growth Trends by Region
- 5.2.1 Global Glycan Analysis and Glycopeptide Analysis Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Glycan Analysis and Glycopeptide Analysis Historic Market Size by Region (2021-2026)
- 5.2.3 Glycan Analysis and Glycopeptide Analysis Forecasted Market Size by Region (2027-2032)
- 5.3 Glycan Analysis and Glycopeptide Analysis Market Dynamics
- 5.3.1 Glycan Analysis and Glycopeptide Analysis Industry Trends
- 5.3.2 Glycan Analysis and Glycopeptide Analysis Market Drivers
- 5.3.3 Glycan Analysis and Glycopeptide Analysis Market Challenges
- 5.3.4 Glycan Analysis and Glycopeptide Analysis Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Glycan Analysis and Glycopeptide Analysis Players by Revenue
- 6.1.1 Global Top Glycan Analysis and Glycopeptide Analysis Players by Revenue (2021-2026)
- 6.1.2 Global Glycan Analysis and Glycopeptide Analysis Revenue Market Share by Players (2021-2026)
- 6.2 Global Glycan Analysis and Glycopeptide Analysis Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Glycan Analysis and Glycopeptide Analysis Head Office and Area Served
- 6.4 Global Glycan Analysis and Glycopeptide Analysis Players, Product Type & Application
- 6.5 Global Glycan Analysis and Glycopeptide Analysis Manufacturers Established Date
- 6.6 Global Glycan Analysis and Glycopeptide Analysis Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Glycan Analysis and Glycopeptide Analysis Market Size (2021-2032)
- 7.2 North America Glycan Analysis and Glycopeptide Analysis Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Glycan Analysis and Glycopeptide Analysis Market Size by Country (2021-2026)
- 7.4 North America Glycan Analysis and Glycopeptide Analysis Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Glycan Analysis and Glycopeptide Analysis Market Size (2021-2032)
- 8.2 Europe Glycan Analysis and Glycopeptide Analysis Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Glycan Analysis and Glycopeptide Analysis Market Size by Country (2021-2026)
- 8.4 Europe Glycan Analysis and Glycopeptide Analysis Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Glycan Analysis and Glycopeptide Analysis Market Size (2021-2032)
- 9.2 Asia-Pacific Glycan Analysis and Glycopeptide Analysis Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Glycan Analysis and Glycopeptide Analysis Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Glycan Analysis and Glycopeptide Analysis Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Glycan Analysis and Glycopeptide Analysis Market Size (2021-2032)
- 10.2 South America Glycan Analysis and Glycopeptide Analysis Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Glycan Analysis and Glycopeptide Analysis Market Size by Country (2021-2026)
- 10.4 South America Glycan Analysis and Glycopeptide Analysis Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Glycan Analysis and Glycopeptide Analysis Market Size (2021-2032)
- 11.2 Middle East & Africa Glycan Analysis and Glycopeptide Analysis Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Glycan Analysis and Glycopeptide Analysis Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Glycan Analysis and Glycopeptide Analysis Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Thermo Fisher
- 12.1.1 Thermo Fisher Company Information
- 12.1.2 Thermo Fisher Business Overview
- 12.1.3 Thermo Fisher Revenue in Glycan Analysis and Glycopeptide Analysis Business (2021-2026)
- 12.1.4 Thermo Fisher Glycan Analysis and Glycopeptide Analysis Product Portfolio
- 12.1.5 Thermo Fisher Recent Developments
- 12.2 Creative Proteomics
- 12.2.1 Creative Proteomics Company Information
- 12.2.2 Creative Proteomics Business Overview
- 12.2.3 Creative Proteomics Revenue in Glycan Analysis and Glycopeptide Analysis Business (2021-2026)
- 12.2.4 Creative Proteomics Glycan Analysis and Glycopeptide Analysis Product Portfolio
- 12.2.5 Creative Proteomics Recent Developments
- 12.3 Bioinformatics Solutions Inc.
- 12.3.1 Bioinformatics Solutions Inc. Company Information
- 12.3.2 Bioinformatics Solutions Inc. Business Overview
- 12.3.3 Bioinformatics Solutions Inc. Revenue in Glycan Analysis and Glycopeptide Analysis Business (2021-2026)
- 12.3.4 Bioinformatics Solutions Inc. Glycan Analysis and Glycopeptide Analysis Product Portfolio
- 12.3.5 Bioinformatics Solutions Inc. Recent Developments
- 12.4 Bruker
- 12.4.1 Bruker Company Information
- 12.4.2 Bruker Business Overview
- 12.4.3 Bruker Revenue in Glycan Analysis and Glycopeptide Analysis Business (2021-2026)
- 12.4.4 Bruker Glycan Analysis and Glycopeptide Analysis Product Portfolio
- 12.4.5 Bruker Recent Developments
- 12.5 NIBSC
- 12.5.1 NIBSC Company Information
- 12.5.2 NIBSC Business Overview
- 12.5.3 NIBSC Revenue in Glycan Analysis and Glycopeptide Analysis Business (2021-2026)
- 12.5.4 NIBSC Glycan Analysis and Glycopeptide Analysis Product Portfolio
- 12.5.5 NIBSC Recent Developments
- 12.6 Waters
- 12.6.1 Waters Company Information
- 12.6.2 Waters Business Overview
- 12.6.3 Waters Revenue in Glycan Analysis and Glycopeptide Analysis Business (2021-2026)
- 12.6.4 Waters Glycan Analysis and Glycopeptide Analysis Product Portfolio
- 12.6.5 Waters Recent Developments
- 12.7 Ludger
- 12.7.1 Ludger Company Information
- 12.7.2 Ludger Business Overview
- 12.7.3 Ludger Revenue in Glycan Analysis and Glycopeptide Analysis Business (2021-2026)
- 12.7.4 Ludger Glycan Analysis and Glycopeptide Analysis Product Portfolio
- 12.7.5 Ludger Recent Developments
- 12.8 Rapid Novor
- 12.8.1 Rapid Novor Company Information
- 12.8.2 Rapid Novor Business Overview
- 12.8.3 Rapid Novor Revenue in Glycan Analysis and Glycopeptide Analysis Business (2021-2026)
- 12.8.4 Rapid Novor Glycan Analysis and Glycopeptide Analysis Product Portfolio
- 12.8.5 Rapid Novor Recent Developments
- 12.9 FyonBio
- 12.9.1 FyonBio Company Information
- 12.9.2 FyonBio Business Overview
- 12.9.3 FyonBio Revenue in Glycan Analysis and Glycopeptide Analysis Business (2021-2026)
- 12.9.4 FyonBio Glycan Analysis and Glycopeptide Analysis Product Portfolio
- 12.9.5 FyonBio Recent Developments
- 12.10 Prolytix
- 12.10.1 Prolytix Company Information
- 12.10.2 Prolytix Business Overview
- 12.10.3 Prolytix Revenue in Glycan Analysis and Glycopeptide Analysis Business (2021-2026)
- 12.10.4 Prolytix Glycan Analysis and Glycopeptide Analysis Product Portfolio
- 12.10.5 Prolytix Recent Developments
- 12.11 Agilent
- 12.11.1 Agilent Company Information
- 12.11.2 Agilent Business Overview
- 12.11.3 Agilent Revenue in Glycan Analysis and Glycopeptide Analysis Business (2021-2026)
- 12.11.4 Agilent Glycan Analysis and Glycopeptide Analysis Product Portfolio
- 12.11.5 Agilent Recent Developments
- 12.12 Asparia Glycomics
- 12.12.1 Asparia Glycomics Company Information
- 12.12.2 Asparia Glycomics Business Overview
- 12.12.3 Asparia Glycomics Revenue in Glycan Analysis and Glycopeptide Analysis Business (2021-2026)
- 12.12.4 Asparia Glycomics Glycan Analysis and Glycopeptide Analysis Product Portfolio
- 12.12.5 Asparia Glycomics Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst